Abstract

In 2007, the International Knockout Mouse Consortium (IKMC) made the ambitious promise to generate mutations in virtually every protein-coding gene of the mouse genome in a concerted worldwide action. Now, 5 years later, the IKMC members have developed high-throughput gene trapping and, in particular, gene-targeting pipelines and generated more than 17,400 mutant murine embryonic stem (ES) cell clones and more than 1,700 mutant mouse strains, most of them conditional. A common IKMC web portal (www.knockoutmouse.org) has been established, allowing easy access to this unparalleled biological resource. The IKMC materials considerably enhance functional gene annotation of the mammalian genome and will have a major impact on future biomedical research.

Highlights

  • Annotation of the human and mouse genomes has identified more than 20,000 protein-coding genes and more than 3,000 noncoding RNA genes

  • Despite the dramatic increase in knowledge of variation in human genomes of healthy and diseased individuals, the normal functions of common forms of most genes are still unknown and the disease significance of rare variants remains obscure as well. Mutation of those genes is required in model organisms

  • Conservation of most aspects of mammalian development, anatomy, metabolism, and physiology between humans and mice is underscored by strong one-to-one orthologous relationships between genes of the two species

Read more

Summary

Introduction

Annotation of the human and mouse genomes has identified more than 20,000 protein-coding genes and more than 3,000 noncoding RNA genes. To deliver the ES cell resource toward this vision of functional annotation, four international programs in Europe and North America were established with the goal of achieving saturation mutagenesis of the mouse genome: EUCOMM, KOMP, NorCOMM, and TIGM (see Table 3). These programs were the founding members of the International Knockout Mouse Consortium (IKMC), fostering groups to work together in a highly coordinated, standardized manner, to share technologies, to maximize output, and to largely avoid duplication of effort (Collins et al 2007). The IKMC consortium has generated mainly conditional and constitutive mutations, with the former class of mutations facilitating tissue-specific assessment of gene function at desired time points, especially in situations where an essential requirement of a gene product in one context can exclude analysis in another

IKMC technology
IKMC ES cell and mouse resources
Mutant mice
IKMC repositories and distribution
Type of material
IKMC web portal
IKMC and beyond
Findings
Full name

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.